Faeezah Patel

Publications

66

Citations

7.3K

h-index

21

Publishing journals

40

Years of publications

20+

Active since

2012

References

2.3K

Institutions

4

1. Divergent Declines: Racial And Socio-Demographic Disparities In Asthma Mortality Trends Across The United States (1999–2023)
   Annals of Allergy Asthma & Immunology, Volume 135, Issue 5, Pages S57-S58, Year 2025
2. Oral health and behavioral problems in children living with and without HIV in South Africa
   AIDS Care, Volume 37, Issue 10, Pages 1667-1679, Year 2025
3. Efficacy, Safety and Tolerability of Dispersible and Immediate Release Abacavir/Dolutegravir/Lamivudine Tablets in Children With HIV: IMPAACT 2019 Week 48 Results.
   The Pediatric infectious disease journal, Volume 44, Issue 8, Pages 777-784, Year 2025
4. Clot twist – D-dimer analysis of healthy adults receiving heterologous or homologous booster COVID-19 vaccine after a single prime dose of Ad26.COV2.S in a phase II randomised open-label trial, BaSiS
   South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, Volume 115, Issue 8, Page e3121, Year 2025
5. Intracellular carbovir‐ and lamivudine‐triphosphate concentrations in PBMC and DBS among children with HIV‐1 receiving ABC/DTG/3TC: Results from IMPAACT 2019
   British Journal of Clinical Pharmacology, Volume 91, Issue S1, Pages 13-13, Year 2025
6. Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
   The Lancet HIV, Volume 11, Issue 4, Pages e211-e221, Year 2024
7. Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study
   The Lancet HIV, Volume 11, Issue 4, Pages e222-e232, Year 2024
8. Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum
   Clinical Infectious Diseases, Volume 78, Issue 6, Pages 1617-1628, Year 2024
9. Safety and immunogenicity of booster vaccination and fractional dosing with Ad26. COV2.S or BNT162b2 in Ad26.COV2.Svaccinated participants
   PLOS Global Public Health, Volume 4, Issue 4, No. e0002703, Page e0002703, Year 2024
10. Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study
    PLOS Global Public Health, Volume 4, Issue 12, No. e0003260, Page e0003260, Year 2024
11. Sociopolitical antecedents influencing COVID-19 vaccine uptake in Pima County, Arizona
    Vaccine X, Volume 22, Pages 100589-100589, Year 2024
12. Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
    The Lancet HIV, Volume 10, Issue 6, Pages e363-e374, Year 2023
13. Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b–2a trial
    The Lancet Infectious Diseases, Volume 23, Issue 3, Pages 295-306, Year 2023
14. Safety surveillance for PrEP in pregnant and breastfeeding women
    Frontiers in Reproductive Health, Volume 5, No. 1221101, Year 2023
15. T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa
    AIDS (London), Volume 37, Issue 1, Pages 105-112, Year 2023
16. Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)
    Vaccine, Volume 41, Issue 23, Pages 3486-3492, Year 2023
17. Microbiota in the oral cavity of school-age children living with HIV who started antiretroviral therapy at young ages in South Africa
    AIDS (London), Volume 37, Issue 10, Pages 1583-1591, Year 2023
18. Disclosure to South African children about their own HIV status over time
    AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Volume 35, Issue 3, Pages 334-340, Year 2023
19. Safety evaluation of the single-dose Ad26. COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial
    PLoS Medicine, Volume 19, Issue 6, No. e1004024, Page e1004024, Year 2022
20. Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants
    Clinical Infectious Diseases, Volume 74, Issue 6, Pages 1047-1054, Year 2022

No publications in the index yet.